Howe & Rusling’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-224
Closed -$8K 943
2020
Q1
$8K Sell
224
-6
-3% -$253 ﹤0.01% 458
2019
Q4
$11K Hold
230
﹤0.01% 465
2019
Q3
$11K Hold
230
﹤0.01% 459
2019
Q2
$10K Sell
230
-3
-1% -$116 ﹤0.01% 457
2019
Q1
$9K Sell
233
-26
-10% -$881 ﹤0.01% 466
2018
Q4
$7K Buy
259
+74
+40% +$2.35K ﹤0.01% 497
2018
Q3
$7K Hold
185
﹤0.01% 572
2018
Q2
$6K Hold
185
﹤0.01% 539
2018
Q1
$4K Sell
185
-30
-14% -$721 ﹤0.01% 660
2017
Q4
$5K Hold
215
﹤0.01% 573
2017
Q3
$6K Hold
215
﹤0.01% 560
2017
Q2
$7K Hold
215
﹤0.01% 563
2017
Q1
$6K Sell
215
-30
-12% -$797 ﹤0.01% 637
2016
Q4
$6K Hold
245
﹤0.01% 643
2016
Q3
$6K Buy
+245
New +$5.36K ﹤0.01% 643

Other funds holding CSII

Howe & Rusling's CSII Position: Q2 2020 in Review

Howe & Rusling sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2020, closing a stake of 224 shares — an estimated $8K sold.

Howe & Rusling first reported a position in CSII in Q3 2016 and held it in 15 quarters. The position peaked at $11K in Q4 2019. 186 funds tracked by Wall St. Rank hold CSII as of Q2 2020.

  • Howe & Rusling reported no remaining Cardiovascular Systems, Inc. position as of Q2 2020 after selling out during the quarter.
  • Howe & Rusling sold 224 Cardiovascular Systems, Inc. shares in Q2 2020, an estimated $8K.
  • Howe & Rusling first reported a position in Cardiovascular Systems, Inc. in Q3 2016 and held it in 15 quarters.
  • Howe & Rusling's Cardiovascular Systems, Inc. position peaked at $11K in Q4 2019.
  • 186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2020.

Based on Howe & Rusling's 13F filing for Q2 2020, filed 15 Jul 2020.